UK Diagnostic Capacity And Spending Below European Average
Executive Summary
The UK’s diagnostics sector has faced “significant underinvestment” over recent years, according to researchers at health think tank The King’s Fund. A new report shows how the UK’s spending on diagnostics compares to other European countries.
You may also be interested in...
Genomic Tests Eliminate ‘Diagnostic Odysseys’ ̶ Why Are They Underutilized In The UK?
Genomic diagnostics provide significant value to the health system, but England’s unclear funding pathways and commissioning processes are preventing these tests from reaching patients, a report by trade body BIVDA reveals.
First Of Its Kind: UK Hospital To Apply For ADA-SCID Gene Therapy Approval
Great Ormond Street Hospital is piloting a new approach to gene therapy delivery in which it will submit a marketing authorization application to the UK regulator for a lentiviral gene therapy used to treat ADA-SCID, a rare disease.
EU Stakeholders Devise Six-Point Plan To Improve Cross-Border Clinical Trials
Sponsors need guidance on ethics requirements and clarity around national regulations to conduct cross-border clinical trials in the EU, a multi-stakeholder forum says.